Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.
Treatment with the inhaled antibiotic Cayston (aztreonam lysine) reduced cough and sputum production, but was not effective against breathlessness and wheezing in people with bronchiectasis, according to an analysis of two ... Read more
People with bronchiectasis who also have human immunodeficiency virus (HIV) are often misdiagnosed, rarely referred to lung specialists, and not offered bronchodilator therapies, a small series of reports covering 14 patients ... Read more
Infection with the human T-cell leukemia virus type 1 (HTLV-1) was identified as a risk factor for bronchiectasis, and one previously unknown, among indigenous adults in central Australia, a case-controlled ... Read more
The risk for all-cause mortality and death related to respiratory conditions and lung cancer is significantly higher in patients with bronchiectasis compared to those without the lung disease, according ... Read more
The incidence of non-cystic fibrosis bronchiectasis is increasing in the United Kingdom (U.K.), with the number of cases much higher than previously thought, according to a survey commissioned by the ... Read more
Pin It on Pinterest